Anaplastic lymphoma kinase inhibition in non–small-cell lung cancer
EL Kwak, YJ Bang, DR Camidge… - … England Journal of …, 2010 - Mass Medical Soc
Background Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase
(ALK) are present in a subgroup of non–small-cell lung cancers, representing 2 to 7% of …
(ALK) are present in a subgroup of non–small-cell lung cancers, representing 2 to 7% of …
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
EL Kwak, YJ Bang, DR Camidge, AT Shaw… - N Engl J …, 2010 - repository.cshl.edu
BACKGROUND: Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma
kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7 …
kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7 …
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
EL Kwak, YJ Bang, DR Camidge, AT Shaw… - The New England …, 2010 - europepmc.org
Background Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase
(ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of …
(ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of …
[引用][C] Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
EL KWAK, YJ BANG… - The New England …, 2010 - pascal-francis.inist.fr
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
[PDF][PDF] Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
EL Kwak, YJ Bang, DR Camidge, AT Shaw… - N Engl J …, 2010 - oncologiatoracica.it
Un obiettivo dell'oncologia moderna è selezionare i pazienti in base alla presenza nel loro
tumore di geni/proteine che identificano sottogruppi specifici, utilizzando poi tali informazioni …
tumore di geni/proteine che identificano sottogruppi specifici, utilizzando poi tali informazioni …
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
EL Kwak, YJ Bang, DR Camidge… - The New England …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase
(ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of …
(ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of …
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
EL Kwak, YJ Bang, DR Camidge… - New England Journal …, 2010 - s-space.snu.ac.kr
BACKGROUND Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma
kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7 …
kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7 …
[PDF][PDF] Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
EL Kwak, YJ Bang, DR Camidge - N Engl J Med, 2010 - core.ac.uk
Metody. Oceniono obecność zmian w obrębie genu ALK w guzach około 1 500 chorych na
niedrobnokomórkowego raka płuca. U 82 chorych na zaawansowanego raka płuca …
niedrobnokomórkowego raka płuca. U 82 chorych na zaawansowanego raka płuca …
[HTML][HTML] Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
EL Kwak, YJ Bang, DR Camidge, AT Shaw… - The New England …, 2010 - ncbi.nlm.nih.gov
BACKGROUND Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma
kinase (ALK) are present in a subgroup of non–small-cell lung cancers, representing 2 to …
kinase (ALK) are present in a subgroup of non–small-cell lung cancers, representing 2 to …
[PDF][PDF] Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
EL Kwak, YJ Bang, DR Camidge - N Engl J Med, 2010 - journals.viamedica.pl
Metody. Oceniono obecność zmian w obrębie genu ALK w guzach około 1 500 chorych na
niedrobnokomórkowego raka płuca. U 82 chorych na zaawansowanego raka płuca …
niedrobnokomórkowego raka płuca. U 82 chorych na zaawansowanego raka płuca …